DiaMedica Therapeutics (DMAC) 10% owner Von Koch bought 1,200,000 shares for $3M at $2.50
Insider transactions reported
Thomas Von Koch (10% owner at DiaMedica Therapeutics Inc., DMAC) reported that they bought 1,200,000 shares for $3M at $2.50 on Jun 28, 2024. After these transactions the filing shows 5,526,435 shares held indirectly (See Footnote 1).
- Reporting person
- Von Koch Thomas
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 28, 2024 | Open-market purchase (P) | Common Shares1 | +1,200,000 | $2.50 | $3M | 5,526,435 indirect |
Holdings before and after
- Common Shares: 4,326,435 to 5,526,435 indirect, See Footnote 1
Footnotes from the filing
- 1. These shares are owned directly by TomEnterprise Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Von Koch report in this DMAC Form 4?
Thomas Von Koch (10% owner at DiaMedica Therapeutics Inc., DMAC) reported that they bought 1,200,000 shares for $3M at $2.50 on Jun 28, 2024. After these transactions the filing shows 5,526,435 shares held indirectly (See Footnote 1).
How many DMAC shares does Von Koch hold after this filing?
The filing shows 5,526,435 shares held indirectly (See Footnote 1) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for DMAC
Earlier insider filings at DMAC
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Follow DMAC and get a push notification the moment its next story breaks.